Literature DB >> 9832572

Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG).

J S Bradley1, S L Kaplan, T Q Tan, W J Barson, M Arditi, G E Schutze, E R Wald, L B Givner, E O Mason.   

Abstract

OBJECTIVE: To describe the clinical and microbiological characteristics of infants and children with bone and joint infections caused by penicillin-susceptible and penicillin-nonsusceptible strains of Streptococcus pneumoniae.
DESIGN: Multicenter, prospective patient accrual; retrospective chart review of identified patients.
SETTING: Eight children's hospitals in the United States. PARTICIPANTS: Forty-two children with bone and/or joint infections prospectively enrolled in the United States Pediatric Multicenter Pneumococcal Surveillance Study from September 1, 1993 to August 31, 1996. OUTCOME MEASURES: Data were collected on multiple variables, including age, gender, race, days of symptoms before and during hospitalization, antibiotic and surgical therapy, laboratory and imaging studies.
RESULTS: Of the 42 children enrolled (21 bone, 21 joint infections), 14 had isolates that were not susceptible to penicillin. Eight of 16 (50%) strains isolated from children who received antibiotics within 4 weeks before hospitalization were not susceptible to penicillin, compared with 4 of 15 (27%) strains isolated from children without previous antibiotic exposure. Clinical response to therapy was similar between children infected by penicillin-susceptible strains compared with those infected by penicillin-nonsusceptible strains, including duration of hospitalization (9.1 days vs 11.2 days), days of intravenous antibiotic therapy (25.3 days vs 24.6 days), days of fever (3.6 days vs 3.1 days), and sequelae (14% vs 7%). The most commonly prescribed single agents for parenteral therapy in definitive treatment were ceftriaxone (36%), penicillin (15%), and clindamycin (15%). Oral therapy followed parenteral therapy in 56% of children. The mean (+/- standard deviation) duration of total antibiotic therapy in children with osteomyelitis was 57.5 +/- 48.6 days (range, 23-196 days) and 29.2 +/- 11.8 days (range, 12-67 days) for arthritis. Late sequelae (long-term destructive changes of the bone or joint) were documented in 5 (12%) children, 4 with osteomyelitis, and 1 with arthritis. Sequelae occurred in 30% of children with long bone osteomyelitis associated with infection in the adjacent joint. The age of children with sequelae was younger than those without sequelae (6.4 months vs 18.6 months).
CONCLUSIONS: The demographic characteristics and anatomic sites of infection in our patients were similar to previously published series collected from single institutions before the emergence of significant antibiotic resistance in S pneumoniae. Our analysis suggests that children infected by penicillin-nonsusceptible strains have a similar clinical response to therapy when compared with children infected by penicillin-susceptible strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832572     DOI: 10.1542/peds.102.6.1376

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Sickle cell trait, hemoglobin C trait, and invasive pneumococcal disease.

Authors:  Katherine A Poehling; Laney S Light; Melissa Rhodes; Beverly M Snively; Natasha B Halasa; Ed Mitchel; William Schaffner; Allen S Craig; Marie R Griffin
Journal:  Epidemiology       Date:  2010-05       Impact factor: 4.822

Review 2.  Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.

Authors:  Tina Q Tan
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Evaluation of disk approximation and single-well broth tests for detection of inducible clindamycin resistance in Streptococcus pneumoniae.

Authors:  James H Jorgensen; M Leticia McElmeel; Letitia C Fulcher; Lesley McGee; Anita Glennen
Journal:  J Clin Microbiol       Date:  2011-07-20       Impact factor: 5.948

4.  Approach to the febrile child: A challenge bridging the gap between the literature and clinical practice.

Authors:  Jean-Bernard Girodias; Benoit Bailey
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

5.  Pediatric osteoarticular infections caused by Streptococcus pneumoniae before and after the introduction of the heptavalent pneumococcal conjugate vaccine.

Authors:  C Lemaître; A Ferroni; C Doit; H Vu-Thien; C Glorion; J Raymond; P Mary; P Wicart; E Bingen; B Ilharreborde; M Lorrot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-09       Impact factor: 3.267

6.  Osteoarticular Infections in Pediatric Hospitals in Europe: A Prospective Cohort Study From the EUCLIDS Consortium.

Authors:  Andreas Trobisch; Nina A Schweintzger; Daniela S Kohlfürst; Manfred G Sagmeister; Matthias Sperl; Andrea J Grisold; Gebhard Feierl; Jethro A Herberg; Enitan D Carrol; Stephane C Paulus; Marieke Emonts; Michiel van der Flier; Ronald de Groot; Miriam Cebey-López; Irene Rivero-Calle; Navin P Boeddha; Paul-Michael Agapow; Fatou Secka; Suzanne T Anderson; Uta Behrends; Uwe Wintergerst; Karl Reiter; Federico Martinon-Torres; Michael Levin; Werner Zenz
Journal:  Front Pediatr       Date:  2022-05-04       Impact factor: 3.418

7.  Successful treatment with azithromycin and rifampicin of penicillin and cephalosporin insensitive pneumococcal osteomyelitis in a child with HIV infection: a case report.

Authors:  Andrew I Riordan; Shazia Adalat; Clive Graham
Journal:  Cases J       Date:  2008-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.